Tirzepatide Side Effects: What to Know Before You Start

Key takeaway: Tirzepatide (Zepbound/Mounjaro) is generally well-tolerated, but common side effects include nausea, vomiting, diarrhea, and constipation, particularly during dose increases. Most side effects are temporary and manageable with proper titration and dietary adjustments. Serious risks are rare but important to know before starting.

Ready to start a GLP-1 weight loss program? Klarity’s licensed providers can evaluate whether GLP-1 medications may be right for you — fully online, same-day appointments available with 2,000+ providers, and many insurance plans may cover your visit. See if you may qualify →

Tirzepatide is the active ingredient in 2 prescription medications: Mounjaro for controlling blood sugar levels in people with type 2 diabetes, and Zepbound for weight loss and weight management. It’s also available as compounded tirzepatide. If your provider recommends any form of tirzepatide, you want to know what tirzepatide side effects are, along with its warnings, contraindications, and potential drug interactions.

What is tirzepatide?

Tirzepatide is the active ingredient in the brand-name prescription medications Zepbound and Mounjaro, and compounded tirzepatide, available from compounding pharmacies. Tirzepatide is a combination GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) agonist. The dual action mimics the body’s natural GIP and GLP-1 hormones, stimulating insulin secretion and slowing gastric emptying, which reduces appetite and supports weight loss.

Tirzepatide Dose-by-Dose: Side Effects & Management

What to know before you take tirzepatide

Before beginning Zepbound, Mounjaro, or compounded tirzepatide, it is important to understand potential warnings, contraindications, possible drug interactions, and possible side effects.

Warnings for tirzepatide

All GLP-1/GIP receptor agonist medications, including Zepbound, carry an FDA boxed warning related to thyroid tumor risk observed in animal studies. If you have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2), discuss the risks and benefits with your provider before starting.

Contraindications

Zepbound, Mounjaro, and compounded tirzepatide should not be taken by people with a personal or family history of MTC or MEN2, or a history of serious hypersensitivity reaction to tirzepatide.

Common tirzepatide side effects

The most common side effects of Zepbound include nausea (up to 29%), diarrhea (up to 23%), vomiting (up to 13%), constipation (up to 17%), abdominal pain (up to 10%), fatigue (up to 7%), hair loss (up to 5%), and injection site reactions (up to 8%). These figures are from Zepbound clinical trials and represent the highest rates observed across the 5 mg, 10 mg, and 15 mg dose groups.

Serious side effects of tirzepatide

Serious side effects are rare (affecting fewer than 10% of patients) but include acute kidney injury, acute gallbladder disease, pancreatitis, hypoglycemia (especially in patients on other diabetes medications), and serious allergic reactions. Contact your provider immediately if you experience severe abdominal pain, signs of dehydration, or symptoms of pancreatitis.

How to reduce tirzepatide side effects

• Adjust your diet: Eat smaller, more frequent meals. Avoid spicy or fatty foods. Sipping ginger tea may help soothe nausea.
• Stay hydrated: GI side effects can lead to dehydration. Drink adequate fluids throughout the day.
• Follow your provider’s directions: Always take tirzepatide exactly as prescribed. Dose adjustments should only be made under medical supervision.

GLP-1 Medications in 2026: What’s New

The GLP-1 landscape has expanded significantly entering 2026, offering patients more options and broader access than ever before.

• Tirzepatide expanded indications: Following FDA approvals in 2024–2025, tirzepatide (Zepbound/Mounjaro) has expanded labeling covering additional cardiovascular and metabolic indications.
• Oral semaglutide for weight loss: Rybelsus (oral semaglutide) is seeing growing uptake for weight management as patients seek needle-free GLP-1 options.
• Triple agonists on the horizon: Retatrutide has shown striking Phase 3 results and may reach the market in 2026–2027.
• Insurance coverage expansion: Ongoing discussions around the Treat and Reduce Obesity Act are pushing toward broader coverage. Coverage varies by plan. Verify your benefits before booking.
• Compounded GLP-1 changes: The FDA’s stance on compounded tirzepatide shifted throughout 2025. Always confirm regulatory status with your provider.
• Telehealth access expanding: Platforms like Klarity offer same-day access to 2,000+ licensed providers.

Ready to start a GLP-1 weight loss program? Klarity’s licensed providers can evaluate whether GLP-1 medications may be right for you — fully online, same-day appointments available with 2,000+ providers, and many insurance plans may cover your visit. See if you may qualify →

Frequently Asked Questions

What are GLP-1 medications?

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) reduce appetite, slow digestion, and support blood sugar regulation. They are widely used for weight management and type 2 diabetes.

How do I get a prescription for tirzepatide or semaglutide?

A licensed provider must evaluate your health history and BMI. Through Klarity, you can complete this entirely online with same-day appointments.

Will my insurance cover GLP-1 medications?

Many commercial plans may cover GLP-1 medications for obesity or metabolic conditions. Coverage varies by plan. Verify your benefits before booking.

How are side effects typically managed?

Most GLP-1 side effects are dose-dependent and manageable through slow titration, dietary adjustments, and hydration. Your Klarity provider can personalize a management plan for you.

How can Klarity help with my GLP-1 treatment?

Klarity’s 2,000+ licensed providers can evaluate your eligibility, prescribe GLP-1 medications if appropriate, and help you manage side effects — all online. See if you may qualify →